.While the biotech assets scene in Europe has slowed quite following a COVID-19 financing boom in 20...
.After rearing $213 million in 2023-- some of the year's largest private biotech shots-- Tome Biosci...
.Accept to this week's Chutes & Ladders, our summary of substantial leadership hirings, shootings...
.Equity capital financing right into biopharma rose to $9.2 billion across 215 deals in the second f...
.Bicara Therapeutics and also Zenas Biopharma have actually supplied new incentive to the IPO market...
.Genentech will definitely shut its cancer immunology study team, and unit mind and also popular cel...
.Kezar Lifestyle Sciences is actually dropping its unpromising stage 1 solid cyst medicine as the bi...
.In spite of izokibep keeping its own newfound winning touch in the medical clinic, Acelyrin is no l...
.Rivus Pharmaceuticals has plumped up the prospects of its own fat-busting, muscle-sparing medicine ...
.Ovid Therapeutics actually uncovered last month that it was trimming its own head count as the prov...